Oxidized transthyretin in amniotic fluid as an early marker of preeclampsia

Journal of Proteome Research

Volumn 6, Issue 1, 2007, Pages 160-170

  Vascotto, Carlo ^a   Salzano, Anna Maria ^b   D'Ambrosio, Chiara ^b   Fruscalzo, Arrigo ^a   Marchesoni, Diego ^a   Di Loreto, Carla ^a   Scaloni, Andrea ^b   Tell, Gianluca ^a   Quadrifoglio, Franco ^a  

^a UNIVERSITY OF UDINE   (Italy)

^b CNR   (Italy)

Author keywords

Amniotic fluid; Preeclampsia; Proteomics; Transthyretin

Indexed keywords

DIMER; MONOMER; PREALBUMIN; RETINOL BINDING PROTEIN; THYROXINE;

ADULT; AMNION FLUID ANALYSIS; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE MARKER; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; OXIDATION; PEPTIDE MAPPING; PLACENTA; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN TRANSPORT; PROTEOMICS; TANDEM MASS SPECTROMETRY; TWO DIMENSIONAL GEL ELECTROPHORESIS;

AMNIOCENTESIS; AMNIOTIC FLUID; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MASS SPECTROMETRY; OXYGEN; PRE-ECLAMPSIA; PREALBUMIN; PREGNANCY; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEOMICS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

EID: 33846562930     PISSN: 15353893     EISSN: None     Source Type: Journal    
DOI: 10.1021/pr060315z     Document Type: Article

References (43)

1. Redman, C. W.; Sargent, I. L. Latest advances in understanding preeclampsia. Science 2005, 308 (5728), 1592-1594.
2. Sibai, B.; Dekker: G.; Kupferminc, M., Pre-eclampsia. Lancet 2005, 365 (9461), 785-799.
3. Raijmakers, M. T. M.; Dechend, R.; Poston, L. Oxidative stress and preeclampsia: rationale for antioxidant clinical trials. Hypertension 2004, 44 (4), 374-380.
4. Chien, P. F.; Arnott, N.; Gordon, A.; Owen, P.; Khan, K. S. How useful is uterine artery Doppler flow velocimetry in the prediction of preeclampsia, intrauterine growth retardation and perinatal death? An overview. Br. J. Obstet. Gynecol. 2000, 107 (2), 196-208.
5. Reis, F. M.; D'Antona, D.; Petraglia, F. Predictive value of hormone measurements in maternal and fetal complications of pregnancy. Endocr. Rev. 2002, 23 (2), 230-257.
6. Ruetschi, U.; Rosen, A.; Karlsson, G.; Zetterberg, H.; Rymo, L.; Hagberg, H.; Jacobsson, B. Proteomic analysis using protein chips to detect biomarkers in cervical and amniotic fluid in women with intra-amniotic inflammation. J. Proteome Res. 2005, 4 (6), 236-242.
7. Vuadens, F.; Benay, C.; Crettaz, D.; Gallot, D.; Sapin, V.; Schneider, P.; Bienvenut, W. V.; Lemery, D.; Quadroni, M.; Dastugue, B.; Tissot, J. D. Identification of biologic markers of the premature rupture of fetal membranes: proteomic approach. Proteomics 2003, 3 (8), 1521-1525.
8. Liberatori, S.; Bini, L.; De, Felice, C.; Magi, B.; Marzocchi, B.; Raggiaschi, R.; Frutiger, S.; Sanchez, J. C.; Wilkins, M. R.; Hughes, G.; Hochstrasser, D. F.; Bracci, R.; Pallini, V. A two-dimensional protein map of human amniotic fluid at 17 weeks' gestation. Electrophoresis 1997, 18 (15), 2816-2822.
9. Nilsson, S.; Ramstrom, M.; Palmblad, M.; Axelsson, O.; Bergquist, J. Explorative study of the protein composition of amniotic fluid by liquid chromatography electrospray ionization Fourier transform ion cyclotron resonance mass spectrometry. J. Proteome Res. 2004, 3 (4), 884-889.
10. Michel, P. E.; Crettaz, D.; Morier, P.; Heller, M.; Gallot, D.; Tissot, J. D.; Reymond, F.; Rossier, J. S. Proteome analysis of human plasma and amniotic fluid by off-gel isoelectric focusing followed by nano-LC-MS/MS. Electrophoresis 2006, 27 (5-6), 1169-1181.
11. Tell, G.; Damante, G.; Caldwell, D.; Kelley, M. R. The intracellular localization of APE1/Ref-1: more than a passive phenomenon? Antioxid. Redox Signaling 2005, 7 (3-4), 367-384.
12. Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72 (1-2), 248-254.
13. Candiano, G.; Bruschi, M.; Musante, L.; Santucci, L.; Ghiggeri, G. M.; Carnemolla, B.; Orecchia, P.; Zardi, L.; Righetti, P. G. Blue silver: a very sensitive colloidal Coomassie G-250 staining for proteome analysis. Electrophoresis 2004, 25 (9), 1327-1333.
14. Shevchenko, A.; Wilm, M.; Vorm, O.; Mann, M. Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal. Chem. 1996, 68 (5), 850-858.
15. Vascotto, C.; Cesaratto, L.; D'Ambrosio, C.; Scaloni, A.; Avellini, C.; Paron, I.; Baccarani, U.; Adani, G. L.; Tiribelli, C.; Quadrifoglio, F.; Tell, G. Proteomic analysis of liver tissues subjected to early ischemia/reperfusion injury during human orthotopic liver transplantation. Proteomics 2006, 6 (11), 3455-3465.
16. Risso, A.; Tell, G.; Vascotto, C.; Costessi, A.; Arena, S.; Scaloni, A.; Cosulich, M. E. Activation of human T lymphocytes under conditions similar to those that occur during exposure to microgravity: a proteomics study. Proteomics 2005, 5 (7), 1827-1837.
17. Paron, I.; D'Elia, A.; D'Ambrosio, C.; Scaloni, A.; D'Aurizio, F.; Prescott, A.; Damante, G.; Tell, G. A proteomic approach to identify early molecular targets of oxidative stress in human epithelial lens cells. Biochem. J. 2004, 378 (Pt 3), 929-937.
18. Cesaratto, L.; Vascotto, C.; D'Ambrosio, C.; Scaloni, A.; Baccarani, U.; Paron, I.; Damante, G.; Calligaris, S.; Quadrifoglio, F.; Tiribelli, C.; Tell, G. Overoxidation of peroxiredoxins as an immediate and sensitive marker of oxidative stress in HepG2 cells and its application to the redox effects induced by ischemia/reperfusion in human liver. Free Radical Res. 2005, 39 (3), 255-268.
19. D'Ambrosio, C.; Arena, S.; Fulcoli, G.: Scheinfeld, M. H.; Zhou, D.; D'Adamio, L.; Scaloni, A. Hyperphosphorylation of JNK-interacting protein 1, a protein associated with Alzheimer disease. Mol. Cell. Proteomics 2006, 5 (1), 97-113.
20. Zhang, W. Z.; Chait, B. T. ProFound: an expert system for protein identification using mass spectrometric peptide mapping information. Anal. Chem. 2000, 72 (11), 2482-2489.
21. Qian, W. J.; Liu, T.; Monroe, M. E.; Strittmatter, E. F.; Jacobs, J. M.; Kangas, L. J.; Petritis, K.; Camp, D. G., II; Smith, R. D. Probability-based evaluation of peptide and protein identifications from tandem mass spectrometry and SEQUEST analysis: the human proteome. J. Proteome Res. 2005, 4 (1), 53-62.
22. Sakura, M.; Nakabayashi, M.; Takeda, Y.; Sato, K. Elevated fetal fibronectin in midtrimester amniotic fluid is involved with the onset of preeclampsia. J. Obstet. Gynaecol. Res. 1998, 24 (1), 73-76.
23. Kupferminc, M. J.; Peaceman, A. M.; Wigton, T. R.; Rehnberg, K. A.; Socol, M. L. Fetal fibronectin levels are elevated in maternal plasma and amniotic fluid of patients with severe preeclampsia. Am. J. Obstet. Gynecol. 1995, 172 (2 Pt 1), 649-653.
24. Anderson, N. L.; Anderson, N. G. High resolution two-dimensional electrophoresis of human plasma proteins. Proc. Natl. Acad. Sci. U.S.A. 1977, 74 (12), 5421-5425.
25. Sanchez, J.-C.; Appel, R. D.; Golaz, O. G.;, Pasquali, C.; Ravier, F.; Bairoch, A.; Hochstrasser, D. F. Inside SWISS-2DPAGE database. Electrophoresis 1995, 16 (7), 1131-1151.
26. Altland, K.; Winter, P. Polyacrilamide gel electrophoresis followed by sodium dodecyl sulphate gradient polyacrylamide gel electrophoresis for the study of the dimer to monomer transition of human transthyretin. Electrophoresis 2003, 24 (14), 2265-2271.
27. Altland, K.; Winter, P.; Sauerborn, M. K. Electrically neutral microheterogeneity of human plasma transthyretin (prealbumin) detected by isoelectric focusing in urea gradients. Electrophoresis 1999, 20 (7), 1349-1364.
28. Jin, Y.; Manabe, T. Direct targeting of human plasma for matrix-assisted laser desorption/ionization and analysis of plasma proteins by time of flight-mass spectrometry. Electrophoresis 2005, 26 (14), 2823-2834.
29. Nakanishi, T.; Sato, T.; Sakoda, S.; Yoshioka, M.; Shimizu, A. Modification of cysteine residue in transthyretin and synthetic peptide: analyses by electrospray ionization mass spectrometry. Biochim. Biophys. Acta 2004, 1698 (1), 45-53.
30. Kishikawa, M.; Sass, J. O.; Sakura, N.; Nakanishi, T.; Shimizu, A.; Yoshioka, M. The peak height ratio of S-sulfonated transthyretin and other oxidized isoforms as a marker for molybdenum cofactor deficiency, measured by electrospray ionization mass spectrometry. Biochim. Biophys. Acta 2002, 1588 (2), 135-138.
31. Kinumi, T.; Shimomae, Y.; Arakawa, R.; Tatsu, Y.; Shigeri, Y.; Yumoto, N.; Niki, E. Effective detection of peptides containing cysteine sulfonic acid using matrix-assisted laser desorption/ionization and laser desorption/ ionization on porous silicon mass spectrometry. J. Mass Spectrom. 2006, 41 (1), 103-112.
32. Wagner, E.; Luche, S.; Penna, L.; Chevallet, M.; Van Dorsselaer, A.; Leize-Wagner, E.; Rabilloud, T. A method for detection of overoxidation of cysteines: peroxiredoxins are oxidized in vivo at the active-site cysteine during oxidative stress. Biochem. J. 2002, 366 (Pt 3), 777-785.
33. Hamilton, J. A.; Benson, M. D. Transthyretin: a review from a structural perspective. Cell. Mol. Life Sci. 2001, 58 (10), 1491-1521.
34. Foss, T. R.; Wiseman, R. L.; Kelly, J. W. The pathway by which the tetrameric protein transthyretin dissociates. Biochemistry 2005, 44 (47), 15525-15533.
35. Liu, K.; Cho, H. S.; Lashuel, H. A.; Kelly, J. W.; Wemmer, D. E. A glimpse of a possible amyloidogenic intermediate of transthyretin. Nat. Struct. Biol. 2000, 7 (9), 754-757.
36. Westermark, P.; Sletten, K.; Johansson, B.; Cornwell, G. G. Fibril in senile systemic amyloidosis is derived from normal transthyretin. Proc. Natl. Acad. Sci. U.S.A. 1990, 87 (7), 2843-2845.
37. Connors, L. H.; Lim, A.; Prokaeva, T.; Roskens, V. A.; Costello, C. E. Tabulation of human transthyretin (TTR) variants. Amyloid 2003, 10 (3), 160-184.
38. Saraiva, M. J. Transthyretin mutations in health and disease. Hum. Mutat. 1995, 5 (3), 191-196.
39. Takaoka, Y.; Ohta, M.; Miyakawa, K.; Nakamura, O.; Suzuki, M.; Takahashi, K.; Yamamura, K.; Sakaki, Y. Cysteine 10 is a key residue in amyloidogenesis of human transthyretin Val30Met. Am. J. Pathol. 2004, 164 (1), 337-345.
40. Zhang, Q.; Kelly, J. W. Cys10 mixed disulfides make transthyretin more amyloidogenic under mildly acidic conditions. Biochemistry 2003, 42 (29), 8756-8761.
41. Monteiro, F. A.; Sousa, M. M.; Cardoso, I.; Barbas, do Amaral, J.; Guimaraes, A.; Saraiva, M. J. Activation of ERK1/2 Map kinases in familial amyloidotic polyneuropathy. J. Neurochem. 2006, 97 (1), 151-161.
42. Sato, T.; Iwaki, M.; Shimogaito, N.; Wu, X.; Yamagishi, S.; Takeuchi, M. TAGE (toxic AGEs) theory in diabetic complications. Curr. Mol. Med. 2006, 6 (3), 351-358.
43. Scaloni, A. Mass spectrometry approaches for the molecular characterization of oxidatively/nitrosatively modified proteins. In Redox Proteomics; from Protein Modifications to Cellular Dysfunction and Diseases; Dalle Donne, I., Scaloni, A., Butterfield, D. A., Eds.; Wiley: Hoboken, NJ, 2006; pp 59-99.